ERBB2 and breast cancer: The increase in TILs is positively correlated with Disease free survival (DFS) and overall survival (OS) among TNBC and HER2 positive BC patients who had received neoadjuvant chemotherapy; however, this correlation is not established in Luminal A type BC.